Basel Medical BMGL
NASDAQ BMGL
$4.68 -0.26 (-5.26%)
At close: Sep 3, 2026 · 4:00 PM EDT

Basel Medical (BMGL) Notes Payables (2024 - 2025)

Basel Medical (BMGL) posted Notes Payables of $2.3 million for Q4 2025, up 40.51% sequentially from $1.6 million in Q2 2025.

Analysis

Basel Medical (BMGL) Notes Payables (2024 - 2025) Analysis & Trends

Basel Medical has reported Notes Payables for 2 years, with the latest figure at $2.3 million in Q4 2025.

  • Quarterly Notes Payables changed N/A year-over-year to $2.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.3 million (changed N/A YoY) and the FY2025 annual result came in at $1.7 million, down 16.63% from the prior year.
  • Notes Payables grew to $2.3 million in Q4 2025 per BMGL's latest filing, from $1.6 million in the prior quarter.
  • Over five years, Notes Payables peaked at $2.3 million in Q4 2025 and troughed at $1.6 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 89.58 Bn 88.57 Bn 15.19 Bn
2 Tenet Healthcare 22.11 Bn 19.94 Bn 4.45 Bn
3 Encompass Health 12.06 Bn 11.93 Bn 1.34 Bn
4 Davita 11.84 Bn 11.16 Bn 1.16 Bn
5 Universal Health Services 10.13 Bn 9.99 Bn 3.29 Bn
6 Ensign 9.92 Bn 9.60 Bn 306.24 Mn
7 Chemed 6.89 Bn 6.85 Bn 221.47 Mn
8 Pacs 6.74 Bn 6.57 Bn 338.46 Mn
9 Concentra Group Holdings Parent 4.30 Bn 4.15 Bn 192.10 Mn
10 Basel Medical 7.33 Mn 6.54 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 887,764.00
Jun 30, 2025 1.63 Mn
Dec 31, 2024 489,275.00
Jun 30, 2024 2.00 Mn